Latest News & Updates

Breaking News

  • 1 minute ago

  • Vaibhavi M.

GSK To Acquire RAPT Therapeutics To Expand Food Allergy Pipeline, Strengthens Allergy Portfolio
Breaking News
Peptinovo Biopharma Receives Ethics Approval To Launch First Human Clinical Trials Of PALM™ Nanotechnology In Australia

Simantini Singh Deo

Other trending news you may like to read

GSK To Acquire RAPT Therapeutics To Expand Food Allergy Pipeline, Strengthens Allergy Portfolio

GSK acquires RAPT Therapeutics to strengthen its allergy pipeline with ozureprubart, a long-acting anti-IgE therapy for food allergies.

Vaibhavi M.

Pharma Now

Peptinovo Biopharma Receives Ethics Approval To Launch First Human Clinical Trials Of PALM™ Nanotechnology In Australia

Peptinovo Biopharma secures Australian ethics approval to launch first-in-human clinical trials for its PALM™ cancer platform.

Simantini Singh Deo

Pharma Now

Rein Therapeutics Secures Orphan Drug Status From The European Medicines Agency For Its Lead IPF Drug Candidate

Rein Therapeutics secures EMA orphan drug designation for LTI-03, strengthening its path in idiopathic pulmonary fibrosis.

Simantini Singh Deo

Pharma Now

Rentschler Biopharma Executive Board Changes: Interim CEO Uwe Buecheler Takes Helm As Leadership Transitions Continue

Rentschler Biopharma reshapes its Executive Board, naming Uwe Buecheler interim CEO to guide the next phase of growth.

Simantini Singh Deo

Pharma Now